4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-25-120106
Chief Executive Officer sold 200,000 shares at an average $14.87 ($2,974,700)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Santos da Silva Jorge Chief Executive Officer | 2025-12-08 | Sale | −130,000 | $15.08 | $1,960,400 | 2,948,577 | D: show line 1 in the form |
| Santos da Silva Jorge Chief Executive Officer | 2025-12-09 | Sale | −70,000 | $14.49 | $1,014,300 | 2,878,577 | D: show line 2 in the form |
| Open-market sales · 200,000 sh · avg $14.87 · $2,974,700 | |||||||
Loading xslF345X05/ownership.xml…